• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

走在前列:社会工作者在迷幻蘑菇治疗抑郁症和药物滥用中的作用。

At the Forefront: Social Workers' Role in Psilocybin Treatment for Depression and Substance Misuse.

机构信息

Claire Parker is a social work student, School of Social Work, University of Texas at Arlington, 501 West Mitchell Street, Arlington, TX 76010, USA.

Bethany Marie Wood, PhD, CSW, is assistant professor, School of Social Work, University of Texas at Arlington, Arlington, TX, USA.

出版信息

Soc Work. 2024 Jun 21;69(3):297-302. doi: 10.1093/sw/swae019.

DOI:10.1093/sw/swae019
PMID:38697188
Abstract

This article underscores the critical role of social workers in harnessing the potential therapeutic benefits of psilocybin for treating major depressive disorder (MDD) and substance use disorder (SUD). Contemporary treatments for MDD often have side effects, and the success rate for SUD treatments remains low. The pervasiveness of MDD, combined with the challenges in treating SUD, highlights a need for innovative treatments. This article provides an overview of the resurgence of literature over the past two decades that illuminates the therapeutic promise of psilocybin for mental health treatment; clinical trials elucidate the efficacy of psilocybin-assisted therapy in mitigating MDD and demonstrate great promise in reducing SUD symptoms. The long-lasting posttreatment effect emphasizes its potential as a novel treatment modality. Furthermore, psilocybin's recognition as a "breakthrough therapy" by the U.S. Food and Drug Administration (FDA) and the accelerating pace of psychedelic reform bills indicate growing acceptance and interest in its therapeutic capacities. Psilocybin-assisted therapy emerges as a potent treatment option, showcasing remarkable effectiveness even after a single dose. Recommendations and pathways for social workers to be involved in psilocybin-assisted therapy investigation, advocacy, and implementation are provided.

摘要

本文强调了社会工作者在利用迷幻蘑菇的潜在治疗益处治疗重度抑郁症(MDD)和物质使用障碍(SUD)方面的关键作用。目前治疗 MDD 的方法往往有副作用,而 SUD 治疗的成功率仍然很低。MDD 的普遍性,加上 SUD 治疗的挑战,凸显了需要创新的治疗方法。本文概述了过去二十年中关于迷幻蘑菇治疗精神健康的文献复兴,阐明了其治疗潜力;临床试验阐明了迷幻蘑菇辅助疗法在缓解 MDD 方面的疗效,并在减少 SUD 症状方面显示出巨大的前景。治疗后的持久效果强调了它作为一种新的治疗模式的潜力。此外,美国食品和药物管理局(FDA)将迷幻蘑菇确认为“突破性疗法”,以及迷幻药改革法案的加速步伐,表明人们对其治疗能力的接受度和兴趣日益增加。迷幻蘑菇辅助疗法是一种有效的治疗选择,甚至在单次剂量后也能显示出显著的效果。本文还为社会工作者提供了参与迷幻蘑菇辅助疗法研究、宣传和实施的建议和途径。

相似文献

1
At the Forefront: Social Workers' Role in Psilocybin Treatment for Depression and Substance Misuse.走在前列:社会工作者在迷幻蘑菇治疗抑郁症和药物滥用中的作用。
Soc Work. 2024 Jun 21;69(3):297-302. doi: 10.1093/sw/swae019.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
5
"I've learned that I'm open-minded to this possibility": A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke.“我了解到自己对这种可能性持开放态度”:一项定性研究,旨在评估裸盖菇素辅助戒烟治疗对吸烟的艾滋病毒感染者的可接受性。
Addict Sci Clin Pract. 2025 Jul 21;20(1):56. doi: 10.1186/s13722-025-00563-0.
6
Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.裸盖菇素、选择性5-羟色胺再摄取抑制剂(SSRI)或艾司氯胺酮治疗抑郁症试验中的对照组结果:一项荟萃分析。
JAMA Netw Open. 2025 Jul 1;8(7):e2524119. doi: 10.1001/jamanetworkopen.2025.24119.
7
The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.迷幻剂在治疗物质使用障碍中的治疗潜力:临床试验综述
Medicina (Kaunas). 2025 Feb 6;61(2):278. doi: 10.3390/medicina61020278.
8
Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.将迷幻辅助疗法从有前途的研究推向常规临床实践:来自实施科学领域的经验教训。
Transl Behav Med. 2024 Nov 25;14(12):744-752. doi: 10.1093/tbm/ibae053.
9
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.加拿大情绪和焦虑治疗网络(CANMAT)工作组报告:治疗重度抑郁症的血清素致幻药物治疗。
Can J Psychiatry. 2023 Jan;68(1):5-21. doi: 10.1177/07067437221111371. Epub 2022 Aug 17.
10
What is needed for the roll-out of psychedelic treatments?迷幻治疗的推广需要什么?
Curr Opin Psychiatry. 2024 Jul 1;37(4):277-281. doi: 10.1097/YCO.0000000000000946. Epub 2024 May 7.